Comparison of Landmark-Based Versus Transverse Carpal Ligament Penetrating Corticosteroid Injection for Carpal Tunnel Syndrome: A Prospective Randomized Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004890

Enrollment

Registered

2020-04-06

Start date

2020-03-31

Completion date

Unknown

Last updated

2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Between March 2020 and March 2021, we prospectively enroll 30 patients between the ages of 18 and 80 who was diagnosed with carpal tunnel syndrome in both hands by clinical symptom

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Between March 2020 and March 2021, 30 patients between the ages of 18 and 80 who was diagnosed with carpal tunnel syndrome in both hands by clinical symptoms, and findings on the physical examination with confirmation by nerve conduction studies 2)Less than a year of symptom occurrence

Exclusion criteria

Exclusion criteria: 1)Thenar atrophy 2)History of previous carpal tunnel surgery or steroid injection 3)Moderate to severe osteoarthritis of the upper extremities 4)History of peripheral vascular disease, polyneuropathy, cervical radiculopathy, focal nerve entrapment other than CTS, hypothyroidism, chronic synovitis such as rheumatoid arthritis 5)Allergic reaction to steroid

Design outcomes

Primary

Measure	Time frame
Boston carpal tunnel questionnaire-symptom	—

Secondary

Measure	Time frame
Pain VAS scale, skin hypopigmentation scale, grip strength, Boston carpal tunnel questionnaire-function	—

Countries

Korea, Republic of

Contacts

Public ContactJongjin Lee

Asan Medical Center

Outcome results